Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

FDA expands efforts to test quality of generics

Monitoring programme to ensure drug copies are equivalent to branded medicines

National Institute for Health and Care Excellence NICE logo

Janssen launches diabetes drug Invokana in UK

Launch coincides with draft NICE recommendation for the SGLT2 inhibitor

- PMLiVE

Teva’s Symbicort generic backed for EU approval

AstraZeneca braces for competition to COPD drug

- PMLiVE

Samsung sets up digital health innovation lab

Forms mobile health partnership to develop new sensors, algorithms and digital health technologies

Par hires Antonio Pera as commercial head

Follows acquisition of Pera’s former company JHP Pharmaceuticals

- PMLiVE

Janssen Invokana combination recommended for European approval

Drug adds metformin to the firm's new SGLT2 inhibitor

The distressing impact of rare diseases

Much more needs to be done to address the problem of effective communications with stakeholders and adequate information for patients affected

- PMLiVE

Developing therapeutic cancer vaccines

Dendreon’s success has paved the way for new candidates

- PMLiVE

PPD set to conduct more clinical trials in Germany

Signs research collaboration with Charité–Universitätsmedizin Berlin

- PMLiVE

UCB names Jean-Christophe Tellier as Doliveux’s successor

He will take over take over leadership at the Belgium pharma company next year

- PMLiVE

GSK’s Anoro backed in Europe for COPD

CHMP recommendation set to expand pharma company’s respiratory portfolio

- PMLiVE

CURx buys rights to Gilead’s lung infection drug

Agrees deal for fosfomycin/tobramycin combination

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links